Yifeng Pharmacy Total Assets
Yifeng Pharmacy total assets. Based on the latest financial reports, Yifeng Pharmacy (603939) holds total assets worth CN¥26.07 Billion CNY (≈ $3.82 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Yifeng Pharmacy worth for the company's overall valuation and market capitalisation.
Total Assets of Yifeng Pharmacy (2011–2024)
Total assets of Yifeng Pharmacy from 2011 to 2024. This chart illustrates how Yifeng Pharmacy's total assets have evolved over time, based on quarterly financial data. See Yifeng Pharmacy stock price for real-time trading data and today's change.
Yifeng Pharmacy - Asset Composition Analysis
Yifeng Pharmacy Total Assets Breakdown (December 2024)
Yifeng Pharmacy total assets breakdown as of December 2024. Yifeng Pharmacy's total assets of CN¥26.07 Billion consist of 56.7% current assets and 43.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.8% |
| Accounts Receivable | CN¥2.63 Billion | 9.4% |
| Inventory | CN¥4.53 Billion | 16.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥486.32 Million | 1.7% |
| Goodwill | CN¥4.77 Billion | 17.1% |
Asset Composition Trend (2011–2024)
This chart illustrates how Yifeng Pharmacy's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 603939 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yifeng Pharmacy's current assets represent 56.7% of total assets in 2024, a decrease from 72.3% in 2011.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2024, down from 26.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 12.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 17.1% of total assets.
Yifeng Pharmacy Competitors by Total Assets
Key competitors of Yifeng Pharmacy based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
SHOP APOTH. UNSP.ADR/010
F:SAE1
|
Germany | €1.21 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.31 Billion |
Yifeng Pharmacy - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.19 | 1.57 |
| Quick Ratio | 1.01 | 0.88 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.48 Billion | CN¥2.39 Billion | CN¥2.92 Billion |
Yifeng Pharmacy - Advanced Valuation Insights
This section examines the relationship between Yifeng Pharmacy's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.47 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 15.9% |
| Total Assets | CN¥27.97 Billion |
| Market Capitalization | $4.80 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yifeng Pharmacy's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Yifeng Pharmacy's assets grew by 15.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Yifeng Pharmacy (2011–2024)
The table below shows the annual total assets of Yifeng Pharmacy from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥27.97 Billion ≈ $4.09 Billion |
+15.90% |
| 2023-12-31 | CN¥24.14 Billion ≈ $3.53 Billion |
+14.72% |
| 2022-12-31 | CN¥21.04 Billion ≈ $3.08 Billion |
+23.38% |
| 2021-12-31 | CN¥17.05 Billion ≈ $2.50 Billion |
+31.68% |
| 2020-12-31 | CN¥12.95 Billion ≈ $1.89 Billion |
+41.14% |
| 2019-12-31 | CN¥9.18 Billion ≈ $1.34 Billion |
+16.61% |
| 2018-12-31 | CN¥7.87 Billion ≈ $1.15 Billion |
+64.52% |
| 2017-12-31 | CN¥4.78 Billion ≈ $699.84 Million |
+13.30% |
| 2016-12-31 | CN¥4.22 Billion ≈ $617.70 Million |
+73.24% |
| 2015-12-31 | CN¥2.44 Billion ≈ $356.56 Million |
+94.79% |
| 2014-12-31 | CN¥1.25 Billion ≈ $183.05 Million |
+21.88% |
| 2013-12-31 | CN¥1.03 Billion ≈ $150.20 Million |
+21.40% |
| 2012-12-31 | CN¥845.45 Million ≈ $123.72 Million |
+0.24% |
| 2011-12-31 | CN¥843.41 Million ≈ $123.42 Million |
-- |
About Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more